Yonhap Infomax NewsNov 11
Kyobo Life Insurance has secured exclusive rights for a new rider covering hereditary female cancer gene and NGS panel tests, marking an industry first in South Korea's insurance sector and expanding personalized cancer care options for women.
#YonhapInfomax #KyoboLifeInsurance #HereditaryCancer #GeneTesting #NGSPanel #ExclusiveRights #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=90190
Kyobo Life Secures Exclusive Rights for Hereditary Female Cancer Gene and Panel Test Coverage

Kyobo Life Insurance has secured exclusive rights for a new rider covering hereditary female cancer gene and NGS panel tests, marking an industry first in South Korea's insurance sector and expanding personalized cancer care options for women.

Yonhap Infomax
N-gated Hacker NewsMay 19, 2025
🚀 Brace yourselves, folks! #23andMe just hit the "sell" button faster than you can say "privacy concerns," offloading their gene-testing biz to the DNA wizards at #Regeneron. 🤖 Meanwhile, #Bloomberg is busy breaking news and breaking our patience with their endless #CAPTCHA tests. 🧬
https://www.bloomberg.com/news/articles/2025-05-19/23andme-sells-gene-testing-business-to-dna-drug-maker-regeneron #geneTesting #privacyConcerns #HackerNews #ngated
Hacker NewsMay 19, 2025

23andMe Sells Gene-Testing Business to DNA Drug Maker Regeneron

https://www.bloomberg.com/news/articles/2025-05-19/23andme-sells-gene-testing-business-to-dna-drug-maker-regeneron

#HackerNews #23andMe #Regeneron #GeneTesting #DNAHealth #Biotech